Literature DB >> 15869921

Quantification of metaphyseal modeling in children treated with bisphosphonates.

Kate Ward1, Christopher T Cowell, David G Little.   

Abstract

There has been recent concern in the literature that the treatment with bisphosphonates in children can have an adverse effect on metaphyseal modeling leading to "drug-induced osteopetrosis". We created a normal database called metaphyseal index in the distal femur so that we could quantify the inwasting modeling process in children on bisphosphonates. Radiographs of the distal femur of 468 normal children who had presented to our institution for orthopedic trauma were examined. A measurement of the distal femoral growth plate width (GPW) was recorded. The femoral width at an interval of 0.5 GPW proximal to the distal femoral growth plate was also recorded (0.5 W). The metaphyseal index was defined as a ratio of 0.5 W/GPW. A graph of the means, one and two standard deviations from the mean, was constructed using the data obtained from this cohort. We found this ratio to be constant with minimal variability regardless of the age or sex of the child. We plotted 20 patients at our institution given bisphosphonates for localized orthopedic complaints. Z scores for girls averaged 0.68 and boys 0.13. Three patients had Z scores >2.0, with values of 2.2, 2.9, and 3.2. Metaphyseal modeling in the distal femur is constant, with slight variation between sexes, resulting in a similar shape of the distal femur throughout childhood. Clinically relevant doses of bisphosphonates given for appropriate indications do not necessarily disturb this process, while the beneficial clinical effect is maintained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869921     DOI: 10.1016/j.bone.2005.02.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

1.  Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors:  Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal:  Pediatr Radiol       Date:  2010-10-30

Review 2.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

3.  ENA Actimineral Resource A restores bone loss and bone quality in ovariectomized rats.

Authors:  Sun Hee Do; Sung-Yong Hwa; Won-Il Jeong; Ji-Won Lee; Hyun-Jung Kim; In-Seon Lee; Kyu-Shik Jeong
Journal:  Mol Cell Biochem       Date:  2006-07-13       Impact factor: 3.396

Review 4.  Use of bisphosphonates for the treatment of stress fractures in athletes.

Authors:  Yosuke Shima; Lars Engebretsen; Junji Iwasa; Katsuhiko Kitaoka; Katsuro Tomita
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-12-02       Impact factor: 4.342

5.  Protocol for a randomised control trial of bisphosphonate (zoledronic acid) treatment in childhood femoral head avascular necrosis due to Perthes disease.

Authors:  Kamal Jamil; Margaret Zacharin; Bruce Foster; Geoffrey Donald; Timothy Hassall; Aris Siafarikas; Michael Johnson; Elaine Tham; Colin Whitewood; Val Gebski; Chris T Cowell; David Graham Little; Craig Frank Munns
Journal:  BMJ Paediatr Open       Date:  2017-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.